Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines

We recently published an article in BMC Medicine looking at the potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study. In their commentary on our article, Lafond et al. highlight the potential importance of the wider benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Waterlow, Naomi R., Procter, Simon R., Eggo, Rosalind M., Jit, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411004/
https://www.ncbi.nlm.nih.gov/pubmed/37559086
http://dx.doi.org/10.1186/s12916-023-02996-3
_version_ 1785086578634260480
author Waterlow, Naomi R.
Procter, Simon R.
Eggo, Rosalind M.
Jit, Mark
author_facet Waterlow, Naomi R.
Procter, Simon R.
Eggo, Rosalind M.
Jit, Mark
author_sort Waterlow, Naomi R.
collection PubMed
description We recently published an article in BMC Medicine looking at the potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study. In their commentary on our article, Lafond et al. highlight the potential importance of the wider benefits of vaccination on cost-effectiveness. Whilst we agree with many points raised in the commentary, we think it raises further interesting discussion points, specifically around model complexity, model assumptions and data availability. These points are both relevant to this manuscript but have wider implications for vaccine cost-effectiveness studies.
format Online
Article
Text
id pubmed-10411004
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104110042023-08-10 Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines Waterlow, Naomi R. Procter, Simon R. Eggo, Rosalind M. Jit, Mark BMC Med Correspondence We recently published an article in BMC Medicine looking at the potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study. In their commentary on our article, Lafond et al. highlight the potential importance of the wider benefits of vaccination on cost-effectiveness. Whilst we agree with many points raised in the commentary, we think it raises further interesting discussion points, specifically around model complexity, model assumptions and data availability. These points are both relevant to this manuscript but have wider implications for vaccine cost-effectiveness studies. BioMed Central 2023-08-09 /pmc/articles/PMC10411004/ /pubmed/37559086 http://dx.doi.org/10.1186/s12916-023-02996-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correspondence
Waterlow, Naomi R.
Procter, Simon R.
Eggo, Rosalind M.
Jit, Mark
Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines
title Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines
title_full Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines
title_fullStr Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines
title_full_unstemmed Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines
title_short Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines
title_sort correspondence to: estimating the full health and economic benefits of current and future influenza vaccines
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411004/
https://www.ncbi.nlm.nih.gov/pubmed/37559086
http://dx.doi.org/10.1186/s12916-023-02996-3
work_keys_str_mv AT waterlownaomir correspondencetoestimatingthefullhealthandeconomicbenefitsofcurrentandfutureinfluenzavaccines
AT proctersimonr correspondencetoestimatingthefullhealthandeconomicbenefitsofcurrentandfutureinfluenzavaccines
AT eggorosalindm correspondencetoestimatingthefullhealthandeconomicbenefitsofcurrentandfutureinfluenzavaccines
AT jitmark correspondencetoestimatingthefullhealthandeconomicbenefitsofcurrentandfutureinfluenzavaccines

Ejemplares similares